Pressure injuries, commonly known as bedsores, often can be deadlier than the condition that causes patients to be bed-bound.
A recent study suggested, that Paxlovid, which is prescribed to patients infected with SARS-CoV-2, who are at risk for severe symptoms, also might help protect against the condition. Researchers found the antiviral also lowered the likelihood of post-acute death and hospitalization.
A review of renal cell carcinoma surveillance in a four-state region found that veterans treated at the VA had a significant incidence of high-risk lesions and poor compliance with follow-up imaging.
The incidence and mortality trends of liver and intrahepatic bile duct cancer in the United States had a dramatic increase from 1975 to 2017, according to data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database.
Veterans have higher rates of cirrhosis, hepatitis C infection, obesity, high alcohol use and diabetes—all of which put them at greater risk of hepatocellular carcinoma. Treatment is challenging, and a new study found that it tends to be inconsistent across regions within VA healthcare, with the West providing more interventions and having longer survival.
The VA has long been a leader in the use of virtual healthcare to improve access to care. When the pandemic caused shutdowns in 2020, virtual care became even more important at the VA.
The dangers of sleep deprivation in military personnel is well-documented; issues include a detrimental effect on readiness and a higher likelihood of errors and injuries.
Rural veterans with serious mental health issues face a disproportionate challenge when seeking mental healthcare services from VA, according to a new report from the Government Accountability Office (GAO).
Sleep issues continue to torment military personnel, and the military is increasingly concerned, because insufficient sleep from chronic insomnia poses a direct threat to military operational readiness. Soldiers in the Army have been most effected. Still, a recent study pointed out that clinical guidelines on treating the issues aren’t always being followed.
Active-duty servicemembers who have mental health disorders need continued support when they are deployed, according to a new study that underscored the need for in-theater healthcare providers. The Uniformed Service University of the Health Sciences-led authors also found that women were more likely to report mental health issues, including serious types, such as bipolar disorder.
Among the most complex patients treated in the VA healthcare system are those with serious mental illnesses, including the more than 120,000 diagnosed with schizophrenia. Those patients not only tend to have worse physical function as they age, but also are more likely to engage in suicidal behavior. To better understand what increases the risk of schizophrenia and other serious mental illnesses, VA researchers are taking a close look at social determinants of health.
A new model suggests that as many as 4.8 million symptomatic cases of respiratory syncytial virus (RSV) occur in the United States among patients 65 and older. That burden is greater than previously recognized, according to another study, which looked at the U.S. and other high-income countries. Recently approved vaccines are likely to be game-changers.
The most common non-Hodgkin lymphoma is diffuse large B-cell lymphoma (DLBCL), and its incidence steadily increases with age, according to recent research.
Already a presumptive condition for Vietnam-era veterans exposed to Agent Orange and military personnel who were at Camp Lejeune in the mid-20th century, follicular lymphoma is also one of the presumptive conditions associated with burn put for Gulf War era and post-9/11 veterans under the new PACT Act. Recent advances have provided a greater understanding of the biological changes that precede the development of FL, a type of non-Hodgkin’s lymphoma, and treatment options are improving.
Even though extended-interval dosing of single-agent pembrolizumab isn’t often used, despite approval from the U.S. Food and Drug Administration, the practice has potential health system and public health benefits, according to a VA study.
Immune checkpoint inhibitors have played a major role in the increased survival of patients with NSCLC. Now, a new study looking at veterans has raised the possibility that common painkillers, nonsteroidal anti-inflammatory drugs (NSAIDs), could play a role in further lengthening survival rates in lung cancer patients being treated with ICIs.
Lineage-switching is a mechanism that can lead to treatment resistance in chronic lymphocytic leukemia (CLL), and, though it’s a rare occurrence, it can be fatal.
In a new study, researchers said they were surprised when a review of first-line chronic lymphocytic leukemia treatment showed racial disparities within the VA healthcare system, which is known for providing equitable care. Black veterans were found to be less likely to receive early novel agents to treat CLL compared to white ones. The situation improved over time, however, and survival rates did not appear to be affected.
Unlike veterans with a variety of types of lymphoma, the expanded list of presumptive conditions for the PACT Act did not include acute myeloid leukemia or other types of leukemia. Because AML occurs primarily in older adults, with an average age at diagnosis of 68, it remains a challenge for clinicians treating veterans receiving care from the VHA. The good news, according to recent studies, is that new combinations of treatment have now come online for older patients.
The White House announced this month that the COVID-19 Public Health Emergency (PHE) has ended and that the United States is “well-prepared to manage the risks of COVID-19 going forward.”
SAN FRANCISCO — Medications approved by the Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis are significantly under-used in the VA Healthcare System, according to a new study. The recent report in the journal Chest looked at the usage...
For veterans diagnosed with idiopathic pulmonary fibrosis due to exposure to toxins during military service, the new PACT Act could literally be a lifesaver. The law assumes a service connection between the condition for certain military servicemembers. That is especially important because the prevalence of IPF more than doubled among veterans over the last decade or so.
Glaucoma is one of the leading causes of irreversible blindness. Avoiding that often requires lifelong adherence to treatment. An intervention led by the Durham, NC, VAMC helped patients not only improve compliance with their treatment regimen but also was a cost-saver. Now, the goal is to roll out the intervention to more VA facilities across the country.
While news reports focus on high demand for glucagon-like peptide-1 receptor agonists (GLP-1 RA), the real story might be widespread under use of those agents and others that reduce the risk of cardiovascular disease and chronic kidney disease progression in patients with Type 2 diabetes.
Concerns have been raised about GLP-1 receptor agonists causing unintended weight loss in older adults. A new VA study has put that worry to rest, finding no significant difference in weight loss with semaglutide use among veterans 65 or older compared to those who are younger. The authors concluded that age does not appear to be a “robust predictor” of semaglutide’s effect on weight.
Colonoscopy might be one of the best tools for detecting colorectal cancer, but that doesn’t mean it’s foolproof. Some cases of CRC are missed, usually because they are too small to detect. The VHA’s 6% rate of post-colonoscopy CRCs is in line with other U.S. healthcare systems and is an indicator of a high-quality CRC screening program, according to a new study.